Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Molecular Partners AG (MLLCF)
OTHER OTC:MLLCF
RESEARCH TOOLSreports
Molecular Partners AG (MLLCF) Stock Price & Analysis
8 Followers
MLLCF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.40 - $10.14
Previous Close$7.5
Volume250.00
Average Volume (3M)458.00
Market Cap
$263.27M
Enterprise Value$60.45M
Total Cash (Recent Filing)CHF186.89M
Total Debt (Recent Filing)CHF3.65M
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Aug 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.01
Shares Outstanding36,368,901
10 Day Avg. Volume135
30 Day Avg. Volume458
Standard Deviation0.20
R-Squared0.02
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.62
Price to Sales (P/S)51.16
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4.09Price Target Upside-18.04% Downside
Rating ConsensusHold
Number of Analyst Covering1
Molecular Partners AG News
Ownership Overview
0.00%
Insiders
0.03% Mutual Funds
0.24% Other Institutional Investors
99.74% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MLLCF FAQ
What was Molecular Partners AG’s price range in the past 12 months?
Molecular Partners AG lowest stock price was $3.40 and its highest was $10.14 in the past 12 months.
What is Molecular Partners AG’s market cap?
Currently, no data Available
When is Molecular Partners AG’s upcoming earnings report date?
Molecular Partners AG’s upcoming earnings report date is Aug 26, 2024 which is in 53 days.
How were Molecular Partners AG’s earnings last quarter?
Molecular Partners AG released its earnings results on Mar 14, 2024. The company reported -$0.666 earnings per share for the quarter, beating the consensus estimate of -$1.074 by $0.407.
Is Molecular Partners AG overvalued?
According to Wall Street analysts Molecular Partners AG’s price is currently Overvalued.
Does Molecular Partners AG pay dividends?
Molecular Partners AG does not currently pay dividends.
What is Molecular Partners AG’s EPS estimate?
Molecular Partners AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Molecular Partners AG have?
Molecular Partners AG has 36,682,587 shares outstanding.
What happened to Molecular Partners AG’s price movement after its last earnings report?
Molecular Partners AG reported an EPS of -$0.666 in its last earnings report, beating expectations of -$1.074. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Molecular Partners AG?
Currently, no hedge funds are holding shares in MLLCF
---
Molecular Partners AG Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.95%
12-Months-Change
Fundamentals
Return on Equity
-30.67%
Trailing 12-Months
Asset Growth
-23.02%
Trailing 12-Months
Company Description
Molecular Partners AG
Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. The company products include Abicipar, MP0250/MP0274 and Clinical Trials. Molecular Partners was founded by Christian Zahnd, Patrick Amstutz, Patrik Forrer, Andreas Plückthun and Michael Tobias Stumpp on November 23, 2004 and is headquartered in Zurich, Switzerland.
---
MLLCF Company Deck
---
MLLCF Earnings Call
Q4 2024
0:00 / 0:00
---
MLLCF Stock 12 Month Forecast
Average Price Target
$4.09
▼(-18.04% Downside)
Technical Analysis
Best Analysts Covering MLLCF
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+82.90%
reiterated a buy rating 4 months ago
Copying Michael Nedelcovych's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +82.90% per trade.
---